Does MYCOPHENOLIC ACID Cause Focal segmental glomerulosclerosis? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Focal segmental glomerulosclerosis have been filed in association with MYCOPHENOLIC ACID (Mycophenolic Acid). This represents 0.3% of all adverse event reports for MYCOPHENOLIC ACID.
55
Reports of Focal segmental glomerulosclerosis with MYCOPHENOLIC ACID
0.3%
of all MYCOPHENOLIC ACID reports
0
Deaths
31
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From MYCOPHENOLIC ACID?
Of the 55 reports, 31 (56.4%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLIC ACID. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLIC ACID Cause?
Off label use (1,402)
Drug ineffective (1,296)
Diarrhoea (811)
Covid-19 (719)
Product use in unapproved indication (702)
Death (645)
Cytomegalovirus infection (638)
Acute kidney injury (608)
Pyrexia (608)
Nausea (519)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which MYCOPHENOLIC ACID Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
MYCOPHENOLIC ACID vs MYFORTIC
MYCOPHENOLIC ACID vs MYRBETRIQ
MYCOPHENOLIC ACID vs NABILONE
MYCOPHENOLIC ACID vs NABUMETONE
MYCOPHENOLIC ACID vs NADOFARAGENE FIRADENOVEC-VNCG